Our team have a track record in acting for Irish and UK financial institutions, alternative finance providers, insolvency practitioners, developers and investors on asset, portfolio and project financing.
The life sciences industry in Ireland has grown remarkably over the last 20 years and has evolved from the 90’s to a new position of global significance.
The growth has seen Ireland become a natural hub for the biotech giants in a similar fashion to the infiltration of the big US data Tech companies. Ireland is now a leading location for pharmaceutical and medical technology companies such as Abbot, Allergan, Boston Scientific, GSK, Lilly, Medtronic, MSD, Novartis, Pfizer and stryker.
The uncertainty around Brexit will likely affect the Life Sciences market particularly in relation to CE Marking and Marketing Authorisation Holders, these issues aside a real opportunity exists also for businesses in this area who wish to expand their presence in the EU-27 remaining member states post Brexit.
As a major player, Ireland must anticipate these Brexit related changes along with the constant innovation and disruptive technologies in the sector. As Ireland’s tech law firm, Leman Solicitors is ideally positioned to help Life Sciences business to capitalise on the opportunities.